VELTASSA

Product Overview

About VELTASSA

VELTASSA is a prescription medication containing the active ingredient PATIROMER (PATIROMER SORBITEX CALCIUM), a non-absorbable, high-capacity cation exchanger. It is used to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood.

Key Benefits & Uses

• Treatment of hyperkalemia in adult patients with chronic kidney disease (CKD) on dialysis.
• Management of hyperkalemia in adult patients with heart failure (HF) with reduced ejection fraction (HFrEF) receiving maximally tolerated doses of ACE inhibitors or angiotensin receptor blockers (ARBs).
• Reduction of serum potassium levels in adult patients with hyperkalemia.

Active Ingredient & Action

PATIROMER (PATIROMER SORBITEX CALCIUM) works by exchanging potassium ions for calcium ions in the gastrointestinal tract, thereby reducing the amount of potassium absorbed into the bloodstream. This helps to lower serum potassium levels and alleviate symptoms associated with hyperkalemia.

Important Notes

VELTASSA is available in tablet form and should be taken orally with water. It is essential to follow the prescribed dosage and administration schedule to ensure optimal efficacy and minimize the risk of adverse effects. Patients with kidney disease or heart failure should be closely monitored by their healthcare provider while taking VELTASSA. Common side effects may include constipation, diarrhea, and nausea. If you experience any unusual symptoms or have concerns about your treatment, consult your doctor or pharmacist for guidance.